Prognostic Scoring System to Risk Stratify Parathyroid Carcinoma

Area of Science:

• Endocrinology
• Oncology
• Surgical Oncology

Background:

• Parathyroid carcinoma is a rare endocrine malignancy.
• An established system for risk categorization is lacking.
• Predicting recurrence-free survival (RFS) is crucial for patient management.

Purpose of the Study:

• To evaluate a prognostic scoring system for RFS in parathyroid carcinoma patients.
• To identify clinical factors associated with tumor recurrence.
• To stratify patients into different risk groups for targeted therapy.

Main Methods:

• Retrospective study of 68 parathyroid carcinoma patients treated between 1980 and 2016.
• Univariate and multivariate Cox proportional hazards regression analyses for RFS.
• Development of a prognostic scoring system based on identified adverse variables.

Main Results:

• The study identified age >65 years, serum calcium >15 mg/dL, and vascular invasion as negative predictors of RFS.
• A prognostic scoring system stratified patients into low (0 variables), moderate (1 variable), and high (2 variables) risk groups.
• The 2-year RFS rates were 93% for low-risk, 72% for moderate-risk, and 27% for high-risk patients (p=0.001).

Conclusions:

• A prognostic scoring system incorporating vascular invasion, age, and serum calcium can predict RFS in parathyroid carcinoma.
• This risk stratification may aid in clinical decision-making regarding adjuvant therapy timing and use.
• Further validation in multiple cohorts is necessary to confirm the system's applicability.